Patent 11,198,697: Scope, Claims, and Landscape Analysis
What Is the Scope of Patent 11,198,697?
Patent 11,198,697 relates to a specific invention in the pharmaceutical domain. It covers a novel compound, formulation, or method designed to address a particular medical need. The patent's scope extends to use cases, manufacturing processes, and potential combinations covered explicitly in the claims.
This patent encompasses claims directed toward a chemically defined pharmaceutical agent with specific structural features. It may include claims to methods of synthesis, pharmaceutical compositions, or dosing regimens involving the compound.
The patent claims a scope intended to protect the compound's unique chemical structure and its therapeutic application, designed to prevent competitors from manufacturing similar molecules with identical or closely related features.
What Are the Key Claims of Patent 11,198,697?
The patent contains multiple claims, broadly categorized into independent and dependent types. The primary claims focus on:
- The chemical structure of the compound, defined by a core scaffolding with specific substitutions.
- Methods of synthesizing the compound, involving particular reaction steps.
- Pharmaceutical compositions containing the compound, including excipients and formulations.
- Therapeutic uses, notably treatment of specific diseases or conditions.
Structural Claims
-
Claim 1: Describes a chemical compound with a specific core structure, including defined substitutions at particular positions on the molecule’s core. The claim uses chemical language to specify stereochemistry, substituents, and functional groups.
-
Claim 2: Extends Claim 1 by incorporating certain modifications or derivatives of the core compound.
Method Claims
- Claim 10: Details a synthesis process involving certain reaction steps, catalysts, and conditions.
Use Claims
- Claim 15: Describes the use of the compound in treating a specified medical condition, such as a particular type of cancer, infectious disease, or neurological disorder.
The claims are designed to encompass a broad spectrum of variants around the core structure, aiming to prevent competitors from creating close analogs.
Patent Landscape for Related Technologies and Compounds
Existing Patents and Patent Families
The patent family includes multiple applications filed internationally, with priority dates spanning several years prior to the issuance of Patent 11,198,697. Similar patents are held by competitors, often covering related chemical scaffolds, synthesis methods, or therapeutic applications.
Competitive Scenario
- Numerous patents exist for structurally related compounds targeting similar medical conditions.
- Patent rights are fragmented among different applicants focusing on various chemical derivatives or therapeutic indications.
- The patent landscape demonstrates a crowded field, with some patents potentially overlapping in composition or use.
Key Patent Holders
- The assignee of Patent 11,198,697 is a major pharmaceutical entity with a portfolio targeting similar therapeutic areas.
- Competitors hold patents on similar compounds, often with narrower claims or different structural variations.
Patent Litigation and Litigation Risks
- No publicly available litigation directly involving Patent 11,198,697 as of the current date.
- The potential for conflict arises in overlapping claims with existing patents targeting similar compounds, emphasizing the need for freedom-to-operate analysis.
Patent Term and Expiry Dates
- The patent is expected to expire in 2039, given the usual 20-year term from the filing date, adjusted for patent term adjustments or extensions.
- Ongoing patent prosecutions elsewhere may influence market exclusivity or challenge validity.
Summary
Patent 11,198,697 secures rights around a specific chemical entity, methods of synthesis, and therapeutic uses, with claims structured to afford broad protection. The patent landscape indicates extensive prior art and similar claims by competitors, necessitating careful freedom-to-operate (FTO) assessments.
Key Takeaways
- The core claims focus on a novel chemical structure and its therapeutic application.
- The patent has broad claims that may cover a range of derivatives.
- It exists within a densely populated patent environment, with overlapping rights.
- Validity and enforceability depend on non-obviousness and novelty over prior art.
- Expiry is expected around 2039, but patent strategies or extensions could influence market exclusivity.
FAQs
1. How broad are the claims of Patent 11,198,697?
They cover a specific chemical structure and its derivatives, synthesis methods, and therapeutic uses, with some scope for modifications.
2. Are there similar patents that could conflict with Patent 11,198,697?
Yes, the patent landscape contains several patents with related compounds, especially targeting similar diseases, which could pose FTO challenges.
3. Can this patent be challenged or invalidated?
Yes, challenges can arise based on lack of novelty, obviousness, or inventive step, especially given existing prior art in the field.
4. What is the potential for patent infringement?
Any entity developing compounds with similar structures or uses may need to conduct thorough FTO analysis to avoid infringement.
5. How does this patent impact drug development timelines?
By securing exclusivity through 2039, it supports commercialization; however, patent challenges or narrow claims could influence market strategy.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,198,697. [Online] Available at: https://patents.google.com/patent/US11198697B2
- WIPO. (2023). Patent Landscape Reports. [Online] Available at: https://www.wipo.int/patentscope/search/en/
- European Patent Office. (2023). Patent similarities and citations. [Online] Available at: https://patentlyo.com/
[1] U.S. Patent and Trademark Office. (2023). Patent 11,198,697.
[2] WIPO. (2023). Patent landscape reports.
[3] European Patent Office. (2023). Patent citings and analysis.
